PDCD1 and hereditary sensory and autonomic neuropathy: Suresh and colleagues reported a significant increase in CD4+ T cells in the BAL samples of CIP patients, primarily those with NSCLC, following treatment with anti-PD-1/PD-L1 inhibitors (57).